New York State Common Retirement Fund’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,252
| Closed | -$16.3K | – | 3443 |
|
|
2024
Q1 | $16.3K | Sell |
10,252
-20
| -0.2% | -$30 | ﹤0.01% | 3159 |
|
|
2023
Q4 | $8.82K | Hold |
10,272
| – | – | ﹤0.01% | 3198 |
|
|
2023
Q3 | $11K | Buy |
10,272
+126
| +1% | +$261 | ﹤0.01% | 3212 |
|
|
2023
Q2 | $26.3K | Hold |
10,146
| – | – | ﹤0.01% | 3216 |
|
|
2023
Q1 | $41.4K | Sell |
10,146
-16,300
| -62% | -$75.3K | ﹤0.01% | 3027 |
|
|
2022
Q4 | $133K | Sell |
26,446
-16
| -0.1% | -$100 | ﹤0.01% | 2879 |
|
|
2022
Q3 | $346K | Buy |
26,462
+3,752
| +17% | +$56.8K | ﹤0.01% | 2520 |
|
|
2022
Q2 | $291K | Sell |
22,710
-74
| -0.3% | -$1.02K | ﹤0.01% | 2618 |
|
|
2022
Q1 | $347K | Buy |
22,784
+20
| +0.1% | +$312 | ﹤0.01% | 2572 |
|
|
2021
Q4 | $403K | Sell |
22,764
-108
| -0.5% | -$2.07K | ﹤0.01% | 2547 |
|
|
2021
Q3 | $481K | Sell |
22,872
-4,335
| -16% | -$95.4K | ﹤0.01% | 2487 |
|
|
2021
Q2 | $537K | Buy |
27,207
+5,207
| +24% | +$122K | ﹤0.01% | 2566 |
|
|
2021
Q1 | $640K | Hold |
22,000
| – | – | ﹤0.01% | 2325 |
|
|
2020
Q4 | $666K | Hold |
22,000
| – | – | ﹤0.01% | 2212 |
|
|
2020
Q3 | $350K | Hold |
22,000
| – | – | ﹤0.01% | 2388 |
|
|
2020
Q2 | $434K | Hold |
22,000
| – | – | ﹤0.01% | 2291 |
|
|
2020
Q1 | $271K | Hold |
22,000
| – | – | ﹤0.01% | 2316 |
|
|
2019
Q4 | $407K | Buy |
22,000
+15,100
| +219% | +$221K | ﹤0.01% | 2402 |
|
|
2019
Q3 | $96K | Hold |
6,900
| – | – | ﹤0.01% | 3042 |
|
|
2019
Q2 | $101K | Buy |
+6,900
| New | +$101K | ﹤0.01% | 3106 |
|
New York State Common Retirement Fund's NGM Position: Q2 2024 in Review
New York State Common Retirement Fund sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 10,252 shares — an estimated $16.3K sold.
New York State Common Retirement Fund first reported a position in NGM in Q2 2019 and held it in 20 quarters. The position peaked at $666K in Q4 2020. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.
- New York State Common Retirement Fund reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- New York State Common Retirement Fund sold 10,252 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $16.3K.
- New York State Common Retirement Fund first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 20 quarters.
- New York State Common Retirement Fund's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $666K in Q4 2020.
- 0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on New York State Common Retirement Fund's 13F filing for Q2 2024, filed 31 Jul 2024.